Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Lesions obtained early in the course of multiple sclerosis (MS) have been studied immunocytochemically, and compared with the early stages of the experimental lesion induced in rats by the intraspinal injection of lipopolysaccharide. Large hemispheric or double hemispheric sections were examined from patients who had died in the course of acute or early relapsing multiple sclerosis. In MS patients exhibiting hypoxia-like lesions [Pattern III; Lucchinetti et al. Ann Neurol (2000) 47: 707-17], focal areas in the white matter showed mild oedema, microglial activation and mild axonal injury in the absence of overt demyelination. In such lesions T-cell infiltration was mild and restricted to the perivascular space. Myeloperoxidase and the inducible form of nitric oxide synthase were expressed primarily by microglia, and the activated form of these cells was associated with extracellular deposition of precipitated fibrin. In addition, these lesions showed up-regulation of proteins involved in tissue preconditioning. When active demyelination started, lesions were associated with massive T-cell infiltration and microglia and macrophages expressed all activation markers studied. Similar tissue alterations were found in rats in the pre-demyelinating stage of lesions induced by the focal injection of bacterial lipopolysaccharide into the spinal white matter. We suggest that the areas of microglial activation represent an early stage of tissue injury, which precedes the formation of hypoxia-like demyelinated plaques. The findings indicate that mechanisms associated with innate immunity may play a role in the formation of hypoxia-like demyelinating lesions in MS.

[1]  S. Dreskin,et al.  Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. , 2007, Immunology letters.

[2]  H. Lassmann,et al.  The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease , 2007, The Journal of experimental medicine.

[3]  S. Vogel,et al.  Up‐regulation of human monocyte CD163 upon activation of cell‐surface Toll‐like receptors , 2007, Journal of leukocyte biology.

[4]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[5]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[6]  K. Suk,et al.  TLR4, but Not TLR2, Signals Autoregulatory Apoptosis of Cultured Microglia: A Critical Role of IFN-β as a Decision Maker 1 , 2005, The Journal of Immunology.

[7]  Kenneth J. Smith,et al.  Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.

[8]  S. Ludwin,et al.  Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. , 2005, Brain : a journal of neurology.

[9]  B. Lambrecht,et al.  Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease , 2005, The Journal of Immunology.

[10]  Dr. Eduard Rindfleisch,et al.  Histologisches Detail zu der grauen Degeneration von Gehirn und Rückenmark. (Zugleich ein Beitrag zu der Lehre von der Entstehung und Verwandlung der Zelle.) , 1863, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[11]  Myriam Bernaudin,et al.  HIF1 and oxygen sensing in the brain , 2004, Nature Reviews Neuroscience.

[12]  D. Witte,et al.  Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo , 2004 .

[13]  H. Lassmann,et al.  Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[15]  B. Trapp,et al.  Generation and characterization of mouse monoclonal antibodies to the myelin-associated glycoprotein (MAG) , 1985, Neurochemical Research.

[16]  D. Witte,et al.  Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. , 2004, The Journal of clinical investigation.

[17]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[18]  M. Cuzner,et al.  Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. , 2003, Brain : a journal of neurology.

[19]  M. Schwab,et al.  Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord , 2003, Glia.

[20]  K. Jellinger,et al.  Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.

[21]  M. Bernaudin,et al.  Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal Rat , 2002, The Journal of Biological Chemistry.

[22]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[23]  H. Schluesener,et al.  The allograft inflammatory factor‐1 family of proteins , 2002, FEBS letters.

[24]  C. Elger,et al.  Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis , 2002, Annals of neurology.

[25]  I. Benjamin,et al.  Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury , 2002, Critical care medicine.

[26]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[27]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[28]  R. Ravid,et al.  Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. , 2001, Brain : a journal of neurology.

[29]  A. Thompson,et al.  Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study , 2001, Multiple sclerosis.

[30]  J. Prineas,et al.  Pathology of Multiple Sclerosis , 2001 .

[31]  M. Bernaudin,et al.  Hypoxia-inducible factor in brain. , 2001, Advances in experimental medicine and biology.

[32]  Ludwin Sk,et al.  The neuropathology of multiple sclerosis. , 2000 .

[33]  G. Semenza,et al.  Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.

[34]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[35]  W. Brück,et al.  Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination , 1999, Multiple sclerosis.

[36]  H. Lassmann,et al.  Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology , 1998, Brain pathology.

[37]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[38]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[39]  J S Wolinsky,et al.  Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.

[40]  M. Esiri,et al.  The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.

[41]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[42]  H. Ploegh,et al.  HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.

[43]  P. Mannucci,et al.  Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen , 1988, The Journal of cell biology.

[44]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[45]  M. Esiri,et al.  MACROPHAGE POPULATIONS ASSOCIATED WITH MULTIPLE SCLEROSIS PLAQUES , 1987, Neuropathology and applied neurobiology.

[46]  M. Esiri,et al.  Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis , 1983, Journal of the Neurological Sciences.

[47]  E. Reinherz,et al.  Multiple sclerosis Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages , 1983, Journal of Neuroimmunology.

[48]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[49]  O. Marburg Die sogenannte akute multiple Sklerose : Encephalomyelitis periaxialis scleroticans , 1906 .